Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Hyphens-Wynzora

More Like This

PR Newswire associated0

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

GRÜNENTHAL LICENSES EXCLUSIVE SOUTH KOREAN RIGHTS TO QUTENZA® TO BCWORLD PHARM

GRÜNENTHAL LICENSES EXCLUSIVE AUSTRALIAN RIGHTS TO QUTENZA® TO CLINECT

Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

APOTEX LICENSES EXCLUSIVE CANADIAN RIGHTS TO QUTENZA® FROM GRÜNENTHAL